Carlson Capital L.P. Takes Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Carlson Capital L.P. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 8,600 shares of the exchange traded fund’s stock, valued at approximately $775,000. SPDR S&P Biotech ETF makes up approximately 0.5% of Carlson Capital L.P.’s portfolio, making the stock its 16th biggest holding.

Several other large investors have also modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $141,284,000. Assetmark Inc. boosted its position in shares of SPDR S&P Biotech ETF by 72,653.0% in the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares during the period. Sivik Global Healthcare LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $29,640,000. Finally, Mirae Asset Securities USA Inc. boosted its position in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.5 %

Shares of SPDR S&P Biotech ETF stock opened at $88.25 on Thursday. The stock has a market cap of $5.82 billion, a PE ratio of 11.47 and a beta of 0.93. The business has a fifty day simple moving average of $91.11 and a 200-day simple moving average of $95.87. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.